Blockade of multiple but not single cytokines abrogates downregulation of angiotensin II type-I receptors and anticipates septic shock

Cytokine

Volumn 49, Issue 1, 2010, Pages 30-38

  Schmidt, Christoph ^a   Höcherl, Klaus ^a   Kurt, Birgül ^a   Moritz, Stefan ^a   Kurtz, Armin ^a   Bucher, Michael ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Angiotensin II type I (AT1) receptors; Cytokines; NF B; Sepsis

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR FUNCTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION REGULATION; GENE SILENCING; HEMODYNAMIC PARAMETERS; ISCHEMIA; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; RNA INTERFERENCE; SEPTIC SHOCK; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE; WILD TYPE;

ANIMALS; CYTOKINES; DEXAMETHASONE; DOWN-REGULATION; GLUCOCORTICOIDS; HEMODYNAMICS; HUMANS; KIDNEY; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NF-KAPPA B; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, SMALL INTERFERING; SHOCK, SEPTIC;

ANIMALIA; MUS;

EID: 71649087774     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.10.006     Document Type: Article

References (40)

1. Abraham E. Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med 25 (1999) 556-566
2. Altavilla D., Squadrito G., Minutoli L., Deodato B., Bova A., Sardella A., et al. Inhibition of nuclear factor-κB activation by IRFI 042, protects against endotoxin-induced shock. Cardiovasc Res 54 (2002) 684-693
3. Arnalich F., Garcia-Palomero E., Lopez J., Jimenez M., Madero R., Renart J., et al. Predictive value of nuclear factor κB activity and plasma cytokine levels in patients with sepsis. Infect Immun 68 (2000) 1942-1945
4. Baeuerle P.A., and Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 12 (1994) 141-179
5. Bohrer H., Qiu F., Zimmermann T., Zhang Y., Jllmer T., Mannel D., et al. Role of NF κB in the mortality of sepsis. J Clin Invest 100 (1997) 972-985
6. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med 26 Suppl. 1 (2000) S64-S74
7. Bucher M., Hobbhahn J., and Kurtz A. Nitric oxide-dependent down-regulation of angiotensin II type 2 receptors during experimental sepsis. Crit Care Med 29 (2001) 1750-1755
8. Bucher M., Hobbhahn J., Taeger K., and Kurtz A. Cytokine-mediated downregulation of vasopressin V(1A) receptors during acute endotoxemia in rats. Am J Physiol Regul Integr Comp Physiol 282 (2002) R979-R984
9. Bucher M., Ittner K.P., Hobbhahn J., Taeger K., and Kurtz A. Downregulation of angiotensin II type 1 receptors during sepsis. Hypertension 38 (2001) 177-182
10. Bucher M., Kees F., Taeger K., and Kurtz A. Cytokines down-regulate α1-adrenergic receptor expression during endotoxemia. Crit Care Med 31 (2003) 566-571
11. Bucher M., and Taeger K. Endothelin-receptor gene-expression in rat endotoxemia. Intensive Care Med 28 (2002) 642-647
12. Chernow B., Rainey T.G., and Lake C.R. Endogenous and exogenous catecholamines in critical care medicine. Crit Care Med 10 (1982) 409-416
13. Gurantz D., Cowling R.T., Varki N., Frikovsky E., Moore C.D., and Greenberg B.H. IL-1beta and TNF-alpha upregulate angiotensin II type 1 (AT 1) receptors on cardiac fibroblasts and are associated with increased AT 1 density in the post-MI heart. J Mol Cell Cardiol 38 (2005) 505-515
14. Hayakawa M., Miyashita H., Sakamoto I., Kitagawa M., Tanaka H., Yasuda H., et al. Evidence that reactive oxygen species do not mediate NF-κB activation. EMBO J 22 (2003) 3356-3366
15. Ikeda Y., Takeuchi K., Kato T., Taniyama Y., Sato K., Takahashi N., et al. Transcriptional suppression of rat angiotensin AT 1a receptor gene expression by interferon-γ in vascular smooth muscle cells. Biochem Biophys Res Commun 262 (1999) 494-498
16. Ikezoe T., Yang Y., Heber D., Taguchi H., and Koeffler H.P. PC-SPES: a potent inhibitor of nuclear factor-κB rescues mice from lipopolysaccharide-induced septic shock. Mol pharmacol 64 (2003) 1521-1529
17. Liu S.F., and Malik A.B. NF-κB activation as a pathological mechanism of septic shock and inflammation. Am J physiol 290 (2006) L622-L645
18. Liu S.F., Ye X., and Malik A.B. Pyrrolidine dithiocarbamate prevents I-κB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs. Mol pharmacol 55 (1999) 658-667
19. Moon S.K., Cha B.Y., and Kim C.H. ERK1/2 mediates TNF-α-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-κB and AP-1: involvement of the ras dependent pathway. J Cell physiol 198 (2004) 417-427
20. Parker S.J., and Watkins P.E. Experimental models of gram-negative sepsis. Br J Surg 88 (2001) 22-30
21. Parrillo J.E. Pathogenetic mechanisms of septic shock. N Engl J Med 328 (1993) 1471-1477
22. Pocock J., Gomez-Guerrero C., Harendza S., Ayoub M., Hernandez-Vargas P., Zahner G., et al. Differential activation of NF-κB, AP-1, and C/EBP in endotoxin-tolerant rats: mechanisms for in vivo regulation of glomerular RANTES/CCL5 expression. J Immunol 170 (2003) 6280-6291
23. Pritts T.A., Moon M.R., Wang Q., Hungness E.S., Salzman A.L., Fischer J.E., et al. Activation of NF-κB varies in different regions of the gastrointestinal tract during endotoxemia. Shock 14 (2000) 118-122
24. Rangel-Frausto M.S., Pittet D., Costigan M., Hwang T., Davis C.S., and Wenzel R.P. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273 (1995) 117-123
25. Russell J.A. Management of sepsis. N Engl J Med 355 (2006) 1699-1713
26. Sasamura H., Nakazato Y., Hayashida T., Kitamura Y., Hayashi M., and Saruta T. Regulation of vascular type 1 angiotensin receptors by cytokines. Hypertension 30 (1997) 35-41
27. Schmidt C., Hocherl K., Schweda F., Kurtz A., and Bucher M. Regulation of renal sodium transporters during severe inflammation. J Am Soc Nephrol 18 (2007) 1072-1083
28. Sheehan M., Wong H.R., Hake P.W., and Zingarelli B. Parthenolide improves systemic hemodynamics and decreases tissue leukosequestration in rats with polymicrobial sepsis. Crit Care Med 31 (2003) 2263-2270
29. Siebenlist U., Franzoso G., and Brown K. Structure, regulation and function of NF-κB. Annu Rev Cell Biol 10 (1994) 405-455
30. Wassmann S., Stumpf M., Strehlow K., Schmid A., Schieffer B., Bohm M., et al. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res 94 (2004) 534-541
31. Wray G.M., and Coakley J.H. Severe septic shock unresponsive to noradrenaline. Lancet 346 (1995) 1604
32. Schmidt C., Höcherl K., Kurt B., and Bucher M. Role of NF-κB dependent induction of cytokines in the regulation of vasopressin V1A receptors during CLP-induced circulatory failure. Crit Care Med 36 8 (2008) 1-11
33. Yamaguchi N., Jesmin S., Zaedi S., Shimojo N., Maeda S., Gando S., et al. Time-dependent expression of renal vaso-regulatory molecules in LPS-induced endotoxemia in rat. Peptides 27 9 (2006) 2258-2270
34. Nin N., Penuelas O., de Paula M., Lorente J.A., Fernandez-Segoviano P., and Esteban A. Ventilation-induced lung injury in rats is associated with organ injury and systemic inflammation that is attenuated by dexamethasone. Crit Care Med 34 (2006) 1093-1098
35. Cumming A., Driedger A., McDonald J., Lindsay R., Solez K., and Linton A.L. Vasoactive hormones in the renal response to systemic sepsis. Am J Kidney Dis 11 (1988) 23-32
36. Ohtani R., Ohashi Y., Muranaga K., Itoh N., and Okamoto H. Changes in activity of the renin-angiotensin system of the rat by induction of acute inflammation. Life Sci 44 (1989) 237-241
37. Hilgendfeldt U., Kienapfel G., Kellermann W., Schott R., and Schmidt M. Renin-angiotensin system in sepsis. Clin Exp Hypertens 9 (1987) 1493-1504
38. Nakamura T., Kasai K., Sekiguchi Y., Banba N., Takahashi K., Emoto T., et al. Elevation of plasma endothelin concentrations during endotoxin shock in dogs. Eur J Pharmacol 205 (1991) 277-282
39. Dunn C., and Horton J. Role of angiotensin II in neonatal sepsis. Circ Shock 40 (1993) 144-150
40. Schaller M., Waeber B., Nussberger J., and Brunner H. Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia. Am J Physiol 249 (1985) H1086-H1092